S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
S&P 500   3,973.75 (+1.86%)
DOW   31,880.24 (+1.98%)
QQQ   293.48 (+1.66%)
AAPL   143.11 (+4.01%)
MSFT   260.65 (+3.20%)
FB   196.23 (+1.39%)
GOOGL   2,235.84 (+2.65%)
AMZN   2,151.14 (-0.03%)
TSLA   674.90 (+1.66%)
NVDA   168.98 (+1.22%)
BABA   87.23 (+0.51%)
NIO   16.00 (-2.68%)
AMD   95.07 (+1.68%)
CGC   5.19 (-5.98%)
MU   69.59 (+1.00%)
T   20.74 (+1.67%)
GE   75.46 (+0.28%)
F   12.83 (+2.64%)
DIS   105.83 (+3.33%)
AMC   11.58 (-3.74%)
PFE   52.88 (+0.78%)
PYPL   81.18 (+0.79%)
NFLX   187.44 (+0.58%)
NASDAQ:SESN

Sesen Bio Earnings Date, Estimates, & History

$0.51
+0.02 (+4.02%)
(As of 05/23/2022 04:00 PM ET)
Add
Compare
Today's Range
$0.50
$0.54
50-Day Range
$0.38
$0.73
52-Week Range
$0.37
$6.04
Volume
2.07 million shs
Average Volume
3.12 million shs
Market Capitalization
$102.60 million
P/E Ratio
2.06
Dividend Yield
N/A
Beta
0.92

Earnings Summary

Upcoming
Earnings Date
Aug. 8Estimated
Actual EPS
(Feb. 28)
$0.02 Beat By $0.10
Consensus EPS
(Feb. 28)
-$0.08
Last Year's Q1 EPS
(3/14/2021)
-$0.11
Skip Charts & View Estimated and Actual Earnings Data

Sesen Bio Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Sesen Bio Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Sesen Bio (NASDAQ:SESN) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20221($0.13)($0.13)($0.13)
Q3 20221($0.12)($0.12)($0.12)
Q4 20221($0.12)($0.12)($0.12)

SESN Earnings Information

Sesen Bio last released its quarterly earnings results on February 28th, 2022. The reported $0.02 EPS for the quarter, beating analysts' consensus estimates of ($0.08) by $0.10. The company earned $20 million during the quarter. Sesen Bio has generated $0.25 earnings per share over the last year ($0.25 diluted earnings per share) and currently has a price-to-earnings ratio of 2.1. Earnings for Sesen Bio are expected to grow in the coming year, from ($0.31) to ($0.27) per share. Sesen Bio has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 8th, 2022 based off prior year's report dates.

Sesen Bio (NASDAQ:SESN) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
8/8/2022
(Estimated)
        
2/28/2022Q4 2021($0.08)$0.02+$0.10$20.00 million    
11/7/20219/30/2021($0.07)$0.36+$0.43($0.40)
8/8/20216/30/2021($0.06)($0.15)($0.09)$0.01$2.40 million$2.23 million
5/9/20213/31/2021($0.08)($0.35)($0.27)($0.35)$4.31 million  
3/14/202112/31/2020($0.11)($0.11)($0.03)
11/14/20209/30/2020($0.08)($0.19)($0.11)($0.19)$11.24 million  
8/10/20206/30/2020($0.09)($0.24)($0.15)($0.24)
5/11/20203/31/2020($0.09)$0.31+$0.40$0.31  
3/16/202012/31/2019($0.08)($0.32)($0.24)$0.16  
11/12/2019Q3($0.1150)($0.13)($0.0150)($0.13)  
8/8/2019Q2 2019($0.09)($0.13)($0.04)$0.41
5/13/2019Q1 2019($0.08)($0.08)($0.08)
3/4/201912/31/2018($0.08)($0.09)($0.01)($0.09)
11/8/20189/30/2018($0.10)($0.18)($0.08)($0.18)
8/14/2018Q2 2018($0.13)($0.16)($0.03)($0.16)
5/15/2018Q1 2018($0.13)($0.11)+$0.02($0.11)
4/4/2018Q4 2017($0.22)($0.22)($0.22)
11/20/2017Q3 2017($0.37)($0.37)($0.37)
8/14/2017Q2 2017($0.30)($0.30)($0.30)
5/4/2017Q1 2017($0.25)($0.25)($0.25)$0.43 million
3/24/2017Q4 2016($0.20)($0.20)($0.25)$0.83 million
11/14/2016Q3 2016$0.91+$0.91$0.91$28.65 million
8/12/2016Q2 2016($0.33)($0.33)($0.33)$0.28 million
5/5/2016Q1 2016($0.39)($0.39)($0.39)$0.23 million
3/24/2016Q4 2015($0.53)($0.53)($0.53)$0.57 million
11/4/2015Q3 2015($0.44)($0.50)($0.06)($0.50)$0.10 million$0.07 million
8/13/2015Q2 2015($0.43)($0.36)+$0.07($0.36)$0.20 million$0.11 million
4/30/2015Q1 2015($0.57)($0.36)+$0.21($0.36)$0.20 million$0.24 million
3/4/2015Q4 2014($0.33)($0.49)($0.16)($0.49)$0.80 million$0.38 million
11/13/2014Q3 2014($0.45)($0.66)($0.21)($0.66)$0.70 million$0.54 million
8/13/2014Q2 2014($0.47)($0.51)($0.04)($0.51)$0.10 million$0.76 million
5/15/2014Q1 2014($0.36)($0.80)($0.44)($0.80)$0.57 million
(Earnings results data provided by Zacks Investment Research)












Sesen Bio (NASDAQ:SESN) Earnings Frequently Asked Questions

When is Sesen Bio's earnings date?

Sesen Bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 8th, 2022 based off last year's report dates. Learn more on SESN's earnings history.

Did Sesen Bio beat their earnings estimates last quarter?

In the previous quarter, Sesen Bio (NASDAQ:SESN) reported $0.02 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.08) by $0.10. Learn more on analysts' earnings estimate vs. SESN's actual earnings.

How can I listen to Sesen Bio's earnings conference call?

The conference call for Sesen Bio's latest earnings report can be listened to online. Listen to Conference Call

How can I read Sesen Bio's conference call transcript?

The conference call transcript for Sesen Bio's latest earnings report can be read online. Read Transcript

How much revenue does Sesen Bio generate each year?

Sesen Bio (NASDAQ:SESN) has a recorded annual revenue of $26.54 million.

How much profit does Sesen Bio generate each year?

Sesen Bio (NASDAQ:SESN) has a recorded net income of -$340 thousand. SESN has generated $0.25 earnings per share over the last four quarters.

What is Sesen Bio's price-to-earnings ratio?

Sesen Bio (NASDAQ:SESN) has a trailing price-to-earnings ratio of 2.06.

What is Sesen Bio's EPS forecast for next year?

Sesen Bio's earnings are expected to grow from ($0.31) per share to ($0.27) per share in the next year.

This page was last updated on 5/23/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.